Alexander Egeberg

Nov 26, 2024 | onlinelibrary.wiley.com | Sejun Kim |Andreas Jensen |Alexander Egeberg

The long-term safety of ustekinumab was good in terms of malignancy, MACE, or severe infections, and no serious hypersensitivity reactions were observed. Ustekinumab patients were characterized by younger age and a higher proportion of males. Ustekinumab was safe regardless of psoriatic arthritis (PsA) status. 1 Introduction Psoriasis (PsO) is a chronic and recurrent inflammatory skin condition that affects approximately 7.9% of the Danish population [1-3].

Oct 31, 2024 | dermatologytimes.com | Kaitlyn Bader |Alexander Egeberg

“As a company, we can do a lot of innovation, but we can only really help patients if we're actually actively able to communicate some of the science and discoveries that we've done. Because if we're not able to tell about all the innovations we've made, then clinicians will not be aware, and that will not benefit patients,” said Alexander Egeberg, MD, PhD, in an interview with Dermatology Times.

Jun 25, 2024 | onlinelibrary.wiley.com | Alexander Egeberg |Jacob P. Thyssen

In 1952, topical hydrocortisone proved effective in reducing severity of atopic dermatitis (AD). The use of topical corticosteroids (TCS) has since become widespread, and it is today used widely to treat acute and chronic inflammatory skin diseases.

Feb 3, 2023 | thelancet.com | Alexander Egeberg |Jacob P. Thyssen

Hidradenitis suppurativa is a chronic inflammatory skin disease affecting the hair follicles that reside in axillary, inguinal, and submammary folds.